Prognostic impact of 21 Gene Recurrence Score, IHC4, and central grade in high-risk HR+/HER2-early breast cancer (EBC): 5-year results of the prospective Phase III WSG PlanB trial.

Authors
Publication date
1 January 2016
Publisher
'American Society of Clinical Oncology (ASCO)'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Kölner UniversitätsPublikationsServer

      redirect
      oaioai:USBKOELN.ub.uni-koeln.de:2...
      Last time updated on 06/12/2020